“The third quarter once again shows the success of our growth strategy. The strong and further rising demand for our innovative and sustainable solutions proves our effective transformation. As an innovative solutions and platform provider, we are a strong partner to our biotech, pharma and cosmetics customers. Our broad range of high-value solutions, devices and products gives us a unique market presence. In addition, our global footprint forms solid foundations on which we can build,“ said Dietmar Siemssen, CEO of Gerresheimer AG.

Gerresheimer generated Group revenue of €382 million in the third quarter of 2021. Compared to the previous year, revenues were organically up by 10.0% and by 9.8% in core business.

The company achieved organic growth of 6.9% in its core business in the first nine months of the year. The Plastics & Devices Division recorded organic growth of 8.0 % in the third quarter of 2021.

Organic revenue in the Primary Packaging Glass Division rose by 12.2% year on year.

The pharma business benefited first and foremost from the unabated rise in demand for biotech drug solutions. Higher demand for solutions for cosmetics and beauty customers also had a positive impact.

Costs for raw materials such as plastic resin, electricity and gas have continued to rise sharply over the past few months. Gerresheimer is taking suitable and short term measures to counteract this increase in input costs.

The company reaffirmed its guidance for the current financial year and its medium-term outlook.

Regardless of rising raw material and energy costs, the company is on track to achieve its absolute targets.

www.gerresheimer.com

Caption: Innovations such as Gerresheimer Gx Elite Vials are driving earnings growth